CN Patent

CN117050006B — 一种吡啶衍生物、中间体、制备方法和应用

Assigned to Shanghai Jiatan Medicinal Technology Co ltd · Expires 2026-02-13 · 0y expired

What this patent protects

本发明公开了一种吡啶衍生物、中间体、制备方法和应用。具体公开了一种如式I所示的化合物或其药学上可接受的盐。本发明的吡啶衍生物能够抑制敏感结核分枝杆菌、耐药结核分支杆菌，特别是贝达喹啉耐药菌株的生长，且具有在药代动力学中消除半衰期更长以及安全性更高的优势。

USPTO Abstract

本发明公开了一种吡啶衍生物、中间体、制备方法和应用。具体公开了一种如式I所示的化合物或其药学上可接受的盐。本发明的吡啶衍生物能够抑制敏感结核分枝杆菌、耐药结核分支杆菌，特别是贝达喹啉耐药菌株的生长，且具有在药代动力学中消除半衰期更长以及安全性更高的优势。

Drugs covered by this patent

bedaquiline-fumarate (BEDAQUILINE FUMARATE)

Patent Metadata

Patent number: CN117050006B
Jurisdiction: CN
Classification: —
Expires: 2026-02-13
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Jiatan Medicinal Technology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.